Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer

Colaboración

Año: 2025

López-Tejada, A; Blaya-Cánovas, JL; Cara, FE; Calahorra, J; Ramírez-Tortos, C; Blancas, I; Delgado-Almenta, V; Muñoz-Parra, F; Avalos-Moreno, M; Sánchez, A; González-González, A; Marchal, JA; Griñán-Lisón, C; Granados-Principal, S

Título: INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES

• D1